Insurance coverage varies by plan, medical criteria, and pharmacy benefits

Weeks 1-4: 1mg weekly injection, Metformin 2000mg daily Weeks 5-12: 4mg weekly injection, Metformin 2000mg daily Weeks 13-24: 8mg weekly injection, Metformin reduced to 1000mg daily Weeks 25-48: 12mg weekly injection, Metformin reduced to 500mg daily View Product Table of Contents Understanding the Type 2 Diabetes Challenge in Canada Metformin: Why It Became the Gold Standard How Retatrutide Works on Blood Sugar Head-to-Head: What the Clinical Data Shows A1C Reduction Breakdown Weight Loss Benefits for Diabetic Patients Side Effect Profiles Compared Cardiovascular Benefits: The Bigger Picture Combination Therapy: Using Both Together Who Might Consider Switching Access and Availability in Canada Cost Considerations for Canadian Patients Practical Injection Guidance for Diabetic Patients Monitoring Your Progress Effectively Long-Term Outlook and Emerging Research Frequently Asked Questions Glossary References Understanding the Type 2 Diabetes Challenge in Canada Type 2 diabetes affects approximately 2.5 million Canadians, with that number projected to reach 3.5 million by 2030

They operate on fundamentally different potency scales, and confusing those scales is one of the most dangerous mistakes a new user can make
it does not predict drug response, select a medication, or recommend a dose
New study counters earlier findings linking drugs with eye disease Image content: This image is available to view online
This is also the right time to discuss whether labs, primary-care follow-up, blood pressure monitoring, diabetes screening, thyroid concerns, or medication interactions should be addressed before treatment starts